FT Weekend: A new weight-loss drug works. Is that good?
This week, we hear about a new 'miracle' weight-loss drug called Wegovy. It has unprecedented clinical results and endorsements from celebrities such as Queen Latifah. But critics say it deals with the symptom but not the cause. Then, we’re joined by Lauren Indvik, the FT's fashion editor. She explains how to…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
Similar episodes from other shows
More like FT News Briefing →
The economics of weight loss, with Rebecca Diamond and Claer Barrett
Why weight loss drugs will change even more than you think
Novo Nordisk, Eli Lilly and the GLP-1 economy
From dementia to heart disease: could weight-loss jabs transform chronic conditions?
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.